UK markets closed

Akso Health Group (8HX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.7050-0.0050 (-0.70%)
At close: 08:10AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
2,218
13,182
6,000
0
6,914
Cost of revenue
2,036
11,913
5,395
0
0
Gross profit
181.939
1,269
605.134
0
6,914
Operating expenses
Research development
-
-
421.186
544.572
1,033
Selling general and administrative
16,544
15,536
3,061
2,087
22,299
Total operating expenses
16,544
15,536
3,061
2,087
23,332
Operating income or loss
-16,363
-14,267
-2,456
-2,087
-16,417
Interest expense
-
0
804.138
2,155
2,499
Total other income/expenses net
-1,401
1,200
-747.818
-52.078
-27,958
Income before tax
-17,764
-13,066
-4,008
-4,293
-46,874
Income tax expense
30.672
17.549
92.816
0
489.955
Income from continuing operations
-17,794
-13,084
-4,101
-4,293
-47,363
Net income
-5,628
-1,360
-16,851
-34,827
-71,198
Net income available to common shareholders
-5,628
-1,360
-16,851
-34,827
-71,198
Basic EPS
-0.24
-0.06
-0.84
-2.13
-4.38
Diluted EPS
-0.24
-0.06
-0.84
-2.13
-4.38
Basic average shares
22,866
22,866
19,871
16,279
16,252
Diluted average shares
22,866
22,866
19,871
16,279
16,252